Pectoralis Minor Release Versus Non-release in RSA

NCT06292169 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-10-23

No results posted yet for this study

Summary

The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are:

* whether releasing the pectoralis minor prophylactically could have better pain relief
* whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes
* whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.

Conditions

  • Reverse Total Shoulder Arthroplasty
  • Rotator Cuff Tear Arthropathy
  • Advanced Glenohumeral Osteoarthritis

Interventions

PROCEDURE

Pectoralis Minor Release

The pectoralis minor is a muscle on the anterior chest wall attaching to the coracoid process. In the group undergoing pectoralis minor release, through the same deltopectoral incision that will not be extended or different as compared to the RSA only group, the pec minor will be exposed on the medial aspect of the coracoid at the upper part of the incision. It will be cut from its insertion on the coracoid while being careful to protect any neurovascular structures.

PROCEDURE

RSA

RSA is the current Standard of Care (SOC)

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Eric Wagner, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-07
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06292169 on ClinicalTrials.gov